Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Ospedale Santa Maria delle Croci
Rávena, ItaliaPublicacións en colaboración con investigadores/as de Ospedale Santa Maria delle Croci (4)
2023
2020
-
Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment
Lung Cancer, Vol. 150, pp. 90-96
-
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
The Lancet Oncology, Vol. 21, Núm. 5, pp. 645-654
2015
-
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
Scientific Reports, Vol. 5